CervoMed Inc. (CRVO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CRVO
- Company CervoMed Inc.
- Price $1.64
- Changes Percentage 2.5
- Change 0.04
- Day Low $1.56
- Day High $1.69
- Year High $10
- Year Low $2.13
- Market Cap $23,331,972
- Price Avg 50 EMA (D) $2.67
- Price Avg 200 EMA (D) $4.25
- Exchange NASDAQ
- Volume 90,389
- Average Volume 380,355
- Open $1.62
- Previous Close $1.6
- EPS -3.28
- PE -0.77
- Earnings Announcement 2026-11-12 12:30:00
- Shares Outstanding $9,258,719
Company brief: CERVOMED INC. (CRVO )
- Healthcare
- Biotechnology
- Dr. John J. Alam M.D.
- https://www.cervomed.com
- US
- N/A
- 05-23-2008
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.